The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $73.81

Today's change+0.32 +0.44%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $73.81

Today's change+0.32 +0.44%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc up (U.S.)$0.32

Quest Diagnostics Inc closed up Friday by (U.S.)$0.32 or 0.44% to (U.S.)$73.81. Over the last five days, shares have gained 0.60% and 10.07% year to date. Shares have outperformed the S&P 500 by 11.83% during the last year.

Key company metrics

  • Open(U.S.) $73.74
  • Previous close(U.S.) $73.49
  • High(U.S.) $74.49
  • Low(U.S.) $73.65
  • Bid / Ask-- / --
  • YTD % change+10.07%
  • Volume1,099,074
  • Average volume (10-day)1,112,553
  • Average volume (1-month)1,067,605
  • Average volume (3-month)1,449,352
  • 52-week range(U.S.) $56.27 to (U.S.) $89.00
  • Beta0.67
  • Trailing P/E21.94×
  • P/E 1 year forward15.50×
  • Forward PEG1.82×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.06%
  • Trailing EPS(U.S.) $3.36
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.06%

Based on its net profit margin of 7.06%, Quest Diagnostics Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue1,9251,8391,8831,904
Total other revenue--------
Total revenue1,9251,8391,8831,904
Gross profit754689701733
Total cost of revenue1,1711,1501,1821,171
Total operating expense1,6241,6111,6261,648
Selling / general / administrative417417420437
Research & development--------
Depreciation / amortization20212324
Interest expense (income), net operating--------
Unusual expense (income)2315916
Other operating expenses, total-78-80
Operating income301228257256
Interest income (expense), net non-operating---45-43-42
Gain (loss) on sale of assets--------
Other--------
Income before tax207112223221
Income after tax12970195139
Income tax, total78422882
Net income11861190129
Total adjustments to net income----0-1
Net income before extra. items11861185129
Minority interest-11-9-10-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items11861185128
Inc. avail. to common incl. extra. items11861190128
Diluted net income11861190128
Dilution adjustment--------
Diluted weighted average shares145146148145
Diluted EPS excluding extraordinary itemsvalue per share0.810.421.250.88
Dividends per sharevalue per share0.380.330.330.33
Diluted normalized EPSvalue per share0.910.481.300.95